U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Toward Global IDMP Implementation: A Focus on Global Use Cases - 11/28/2023
  1. News & Events for Human Drugs

Virtual | Virtual

Event Title
Toward Global IDMP Implementation: A Focus on Global Use Cases
November 28, 2023

Date:
November 28, 2023
Time:
1:00 p.m. - 2:30 p.m. ET

Visit CDER Small Business and Industry Assistance Page

ABOUT THIS EVENT

Identification of Medicinal Products (IDMP) is a set of five standards developed by the International Organization for Standardization (ISO) (www.iso.org). Together, these five standards, along with their respective technical specifications, will make it possible to uniquely identify medicinal products globally and to standardize the electronic exchange of medicinal product data. FDA’s recent guidance on IDMP explains FDA’s position and progress on aligning the Agency’s standards to IDMP standards to identify and describe marketed medicinal products with the goal of harmonizing the standards for the international exchange of medicinal product data.

This webinar will provide an overview of the FDA Guidance on IDMP – Implementation and Use, along with a status update of the international activities focused on global implementation. The primary focus of the webinar is to discuss specific pharmacovigilance and drug shortage use cases that demonstrate the global benefits that IDMP standards will deliver.

INTENDED AUDIENCE

  • Regulatory affairs professionals working on data standards, pharmacovigilance, product labelling, and electronic regulatory submissions
  • Consultants focused on data standards, pharmacovigilance, product labelling, and electronic regulatory submissions
  • IT professionals focused on the electronic exchange of medicinal product information
  • International regulators and industry focused on data standards, pharmacovigilance, product labelling, and electronic regulatory submissions

TOPICS COVERED

  • Overview of the FDA Guidance on IDMP – Implementation and Use
  • Status of the international projects focused on global implementation
  • FDA will discuss specific pharmacovigilance and drug shortage use cases demonstrating the value-added impact that IDMP will deliver.

FDA SPEAKERS

Ron Fitzmartin, PhD, MBA
Sr. Informatics Advisor
Data Standards Branch (DSB)
Division of Informatics (DI)
Office of Regulatory Operations (ORO)
Center for Biologics Evaluation and Research (CBER) | FDA

Ta-Jen Chen
Sr. Project Management Officer
Data Standards Staff (DSS)
Office of Strategic Programs (OSP)
Center for Drug Evaluation and Research (CDER) | FDA

Sonja Brajovic, MD
Medical Officer
Regulatory Science Staff (RSS)
Office of Surveillance and Epidemiology (OSE)
CDER | FDA

FDA RESOURCES

Event Materials

Title File Type/Size
Toward Global IDMP Implementation: A Focus on Global Use Cases.pdf pdf (12.13 MB)
Back to Top